The rapidly evolving field of digital therapeutics is “top of mind” for many people. There is widespread interest from patients, providers, payers, tech companies, and the biopharmaceutical industry.
However, it’s also a confusing topic. There are conflicting definitions of “digital therapeutics,” it’s not clear who’s best equipped to develop and deliver them, and uncertainty abounds regarding business models, commercialization, and more.
This e-book provides a solid introduction. It will help readers make sense of the potential for this new class of products, address key topics within the field, and provide the insights needed to begin addressing strategic questions regarding digital therapeutics.
